生命科学资讯
生物技术与制药领域的最新动态
Illumina: What Is Next In This Sequence? (NASDAQ:ILMN) - Seeking Alpha
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore
核苷酸市场即将迎来繁荣 | 安捷伦科技 • 伯乐实验室 • 凯杰公司 - openPR.com
Nucleotide Market Is Going to Boom | Agilent Technologies • Bio-Rad Laboratories • QIAGEN - openPR.com
Is Waters Corporation the Quiet Wall Street Cheat Code Everyone’s Sleeping On? - AD HOC NEWS
利润回顾：安捷伦科技公司是否显示内部购买 - 季度收益总结与AI驱动股价预测 - baoquankhu1.vn
Profit Recap: Is Agilent Technologies Inc showing insider buying - Quarterly Earnings Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
赛默飞世尔科技公司（TMO）：看涨理论分析 - 内部人士观察
Thermo Fisher Scientific Inc. (TMO): A Bull Case Theory - Insider Monkey
FDA授予iRegene公司NouvNeu001再生医学先进疗法认定，巩固其作为全球首个同时获得FTD与RMAT认证的iPSC疗法的领先地位。
FDA Grants RMAT Designation to iRegene’s NouvNeu001, Cementing its Lead as the World’s First iPSC Therapy with Both FTD and RMAT Recognitions
阿斯利康签署6.3亿美元协议，获得AbelZeta装甲CAR-T剩余权益。
AstraZeneca pens $630M pact to secure remaining rights to armored CAR-T from AbelZeta
Thermo Fisher Scientific Inc.: BCC Research发布全方位360度公司分析 - 雅虎财经
Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis - Yahoo Finance
Zacks分析师博客聚焦Visa、AMD与赛默飞世尔科技 - Zacks投资研究
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific - Zacks Investment Research
Zincure合成新型MMP-9抑制剂
Zincure synthesizes new MMP-9 inhibitors
Chong Kun Dang Pharmaceutical discovers new GLP-1R agonists
Chong Kun Dang Pharmaceutical discovers new GLP-1R agonists
Negio Therapeutics获得α2-肾上腺素受体激动剂专利
Negio Therapeutics patents α2-adrenoceptor agonists
南京正大天晴制药发现新型生长抑素SST2受体激动剂
Nanjing Chia Tai Tianqing Pharmaceutical identifies new somatostatin SST2 receptor agonists
深圳新罗塞塔生物科学公司披露新型毒蕈碱M2受体拮抗剂
Shenzhen Newrosetta Biosciences discloses new muscarinic M2 receptor antagonists
凯茜·伍德周度持仓更新：增持博通、AMD，减持特斯拉、Illumina——MSN报道
Cathie Wood's weekly update: buys Broadcom, AMD; sells Tesla, Illumina - MSN
免疫生物技术公司Agomab与专注眼科的SpyGlass成为最新一批公布IPO计划的生物科技企业。
Immunology biotech Agomab, eye-focused SpyGlass are latest biotechs to share IPO ambitions
安捷伦科技公司（NYSE:A）今日标普500指数表现全球实验室支持 - Kalkine媒体
Agilent Technologies, Inc. (NYSE:A) S&P 500 Today Global Lab Support - Kalkine Media
气相色谱系统市场预计将达到7203.59万美元 - openPR.com
Gas Chromatography Systems Market to Reach US$ US$7,203.59 - openPR.com